This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

MESOBLAST CHIEF EXECUTIVE HONOURED AT THE VATICAN WITH INAUGURAL PONTIFICAL AWARD FOR INNOVATION

NEW YORK and MELBOURNE, Australia, April 12, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB, USOTC:MBLTY) is pleased to announce that its Chief Executive Professor Silviu Itescu today received the inaugural 'Key Innovation Award 2013' from the Pontifical Council for Culture and The Stem for Life Foundation. This unique recognition was announced during the Second International Vatican Adult Stem Cell Conference  currently being held in Vatican City.  The award was presented by Monsignor Tomasz Trafny, Head of the Science and Faith Department at the Pontifical Council for Culture, and Dr Robin Smith, President for the Stem for Life Foundation. Dr Smith said the award was being given "with admiration of Professor Itescu's leadership and ingenuity in translational science and clinical medicine within the field of adult stem cell therapy. "In every emerging industry, there are always individuals who stand out as pioneers.  Professor Itescu has distinguished himself as an innovator in the field of regenerative medicine, one that has brought hope and healing to a world struggling to manage chronic disease and serious medical conditions." "I am honoured to have received such a distinguished award", Professor Itescu said.  "It signifies important recognition of the contributions made by the dedicated team at Mesoblast striving to deliver safe and effective new therapies at the forefront of regenerative medicine". Mesoblast's achievements using its allogeneic adult stem cell technology platform in various conditions, including cardiovascular diseases, will be highlighted at the conference by Dr Emerson C. Perin, Director, Clinical Research for Cardiovascular Medicine and Medical Director, Stem Cell Center, Texas Heart Institute, and Mesoblast's Chief Medical Officer, Dr Donna Skerrett. The Second International Vatican Adult Stem Cell Conference, entitled Regenerative  Medicine: a Fundamental Shift in Science & Culture, is being held within The Vatican, from 11-13 April 2013. The event is part of a five-year collaboration between The Vatican's Pontifical Council for Culture and its Foundation, called STOQ International (Science, Theology and the Ontological Quest), The Stem for Life Foundation, a not-for-profit organization devoted to raising global awareness of the therapeutic potential of adult stem cells, and NeoStem Inc.

Mesoblast Limited

Mesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes and kidney disease, orthopedic spine conditions, and cardiovascular disorders. www.mesoblast.com

CONTACT: Julie Meldrum
         Global Head of Corporate Communications
         Mesoblast Limited
         +61396396036
         +61419228128

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7870 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs